Search results
Results From The WOW.Com Content Network
The International Prognostic Index (IPI) is a clinical tool developed by oncologists to aid in predicting the prognosis of patients with aggressive non-Hodgkin's lymphoma. Previous to IPI's development, the primary consideration in assessing prognosis was the Ann Arbor stage alone, but this was increasingly found to be an inadequate means of ...
The Nottingham prognostic index (NPI) is used to determine prognosis following surgery for breast cancer. [1] [2] Its value is calculated using three pathological criteria: the size of the tumour; the number of involved lymph nodes; and the grade of the tumour. [1] It is calculated to select patients for adjuvant treatment.
Prognosis (Greek: πρόγνωσις "fore-knowing, foreseeing"; pl.: prognoses) is a medical term for predicting the likelihood or expected development of a disease, including whether the signs and symptoms will improve or worsen (and how quickly) or remain stable over time; expectations of quality of life, such as the ability to carry out daily activities; the potential for complications and ...
International Prognostic Index, a medical tool used in oncology to predict the outcome of lymphoma patients; International Protein Index, a database covering information about the proteomes of humans, mice and other animals; Integrated Pulmonary Index, a single value that describes the patient's respiratory status
The USC/Van Nuys prognostic index (VNPI) classifies ductal carcinoma in situ (DCIS) into dissimilar risk categories that may be treated accordingly. The choice of which treatment to receive can be substantially influenced by comorbidity assessments. Familial breast cancers may potentially undergo dissimilar treatment (such as mastectomy).
An ideal prognostic variable is easily measured or calculated, and provides an exact estimation of how long time the system can continue to operate before maintenance or replacement will be required. Real prognostic variables are usually known with some uncertainty, may be difficult to measure, and their correlation to the system's state of ...
Prognostic markers are biomarkers used to measure the progress of a disease in the patient sample. [1] Prognostic markers are useful to stratify the patients into groups, guiding towards precise medicine discovery. The widely used prognostic markers in cancers include stage, size, grade, node and metastasis. In addition to these common markers ...
The Central Nervous System – International Prognostic Index (CNS-IPI) has emerged as a valuable tool for risk stratification. Developed by the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) in 2016, the CNS-IPI integrates factors from the International Prognostic Index (IPI) along with additional considerations such as kidney and ...